News | March 03, 2014

Hologic's Total Breast Tomosynthesis Solution Featured at ECR

Hologic Total Breast Tomosynthesis Mammography Systems Women's Health

March 3, 2013 — Hologic Inc. is a developer, manufacturer and supplier of diagnostic products, medical imaging systems and surgical products, with an emphasis on serving the healthcare needs of women. It will showcase its portfolio of products for breast cancer screening and diagnosis, breast biopsy, osteoporosis risk assessment and extremity imaging at the annual meeting of the European Society of Radiology, in Vienna, Austria, March 6-10. Hologic is offering three tomosynthesis-related events at ECR.

 

ECR Satellite Symposium

"Breast Tomosynthesis: Evolution and Adoption Across Europe," March 8, 2-3:30 p.m. in the Austria Center Vienna, Room C. The symposium will feature speakers from various countries throughout Europe, including:

  • Fiona Gilbert, Cambridge, United Kingdom - The use of breast tomosynthesis in the screening assessment in the UK
  • Melcior Sentis, Sabadell, Spain - Using breast tomosynthesis with C-View 2-D images and tomosynthesis guided biopsy: our experience in Spain
  • Francesca Caumo, Verona, Italy - Diagnostic and interventional use of breast tomosynthesis: our experience in Italy
  • Martin Sonnenschein, Bern, Switzerland - The use of breast tomosynthesis with C-View images and tomosynthesis guided biopsy in daily practice: our experience in Switzerland
  • Per Skaane, Oslo, Norway - Incorporating breast tomosynthesis in a population-based screening program: our experience in Oslo

 

Breast Tomosynthesis Education Sessions

There will be eight 75-minute breast tomosynthesis education sessions from March 7-9. Each session includes hands-on experience reading breast tomosynthesis images in combination with conventional and generated (C-View) 2-D images.

 

Breast Biopsy Guided by Tomosynthesis Training Workshops 

There will be 14 breast biopsy guided by tomosynthesis training workshops, March 7-9. Each workshop will include an overview of the first clinical experiences with vacuum-assisted breast biopsies guided by tomosynthesis prior to a demonstration of a phantom procedure. There will be time at the end of each session for hands-on training.

 

Other products on display include:

  • Horizon Bone Densitometry (DXA) System. Shown for the first time in Europe, Hologic's Horizon DXA system provides a single platform for osteoporosis and obesity assessment, visualization of abdominal aortic calcifications and an innovative new feature enabling atypical femur fracture assessment.
  • Selenia Dimensions Avia Package. A cost-effective option for customers seeking a 2-D screening only or 2-D screening and diagnostic solution, this package provides an upgrade pathway for interventional and tomosynthesis capabilities.
  • Fluoroscan InSight-FD Mini C-arm. Featuring flat panel detector technology, this system is designed specifically for orthopedic and extremity surgeons and offers a thin profile and improved workspace access with enhanced ease of positioning.
  • Breast Biopsy Systems. Hologic's Eviva and ATEC breast biopsy systems are designed to conduct minimally invasive biopsy procedures under stereotactic, ultrasound or MRI guidance.

 

For more information, visit www.hologic.com

Related Content

Digital Mammography Increases Breast Cancer Detection
News | Mammography | January 16, 2019
The shift from film to digital mammography increased the detection of breast cancer by 14 percent overall in the United...
Artificial Intelligence Used in Clinical Practice to Measure Breast Density
News | Artificial Intelligence | January 15, 2019
An artificial intelligence (AI) algorithm measures breast density at the level of an experienced mammographer,...
Sponsored Content | Videos | Breast Imaging | January 11, 2019
Supplemental screening with ABUS helps personalize breast care for women with dense breasts and offers advanced...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Breast Cancer Patients Have Less Heart Damage With Heart Drug and Trastuzumab
News | Cardio-oncology | January 03, 2019
Breast cancer patients who take a heart drug at the same time as trastuzumab have less heart damage, according to a...
Opto-Acoustic Imaging Helps Differentiate Breast Cancer Molecular Subtypes
News | Ultrasound Women's Health | December 20, 2018
Seno Medical Instruments Inc. (Seno Medical) reported results of a study demonstrating that morphologic and functional...
Densitas Enters Platform Partnership With Blackford
News | Breast Density | December 19, 2018
Breast imaging analytics company Densitas Inc. announced the signing of a new Alliance Partner Agreement with Blackford...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RSNA Study Shows Real-Time Indicator Improves Mammographic Compression
News | Mammography | December 12, 2018
Sigmascreening recently announced that more than 100,000 women have had mammography exams with the Sensitive Sigma...
Massachusetts Superior Court Grants Hologic Preliminary Injunction in Trade Secrets Lawsuits
News | Mammography | December 12, 2018
December 12, 2018 — A Massachusetts Superior Court granted a preliminary injunction in lawsuits by Hologic against Ch